当前位置：首页 > 文献互助 > 互助详情

Izalontamab Brengitecan (Iza-Bren), a First-in-Class EGFR-HER3 Bispecific Antibody-Drug Conjugate in Extensive-Stage Small Cell Lung Cancer: Results From a Phase Ib Study复制

用户EO9nReo4Hj6s 55分钟前 14 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-09-09 17:49:26 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1200/jco-26-00243复制

文献链接: https://ascopubs.org/doi/10.1200/JCO-26-00243复制

其他信息:

出版社: American Society of Clinical Oncology (ASCO)
作者: Yuanyuan Zhao; Hongyun Zhao; Qiming Wang; Kunyu Yang; Yongsheng Li; Zhenming Fu; Weihua Yang; Zhiyong He; Yongsheng Wang; Yuxiang Ma; Yunpeng Yang; Wenfeng Fang; Sa Xiao; Hai Zhu; Yi Zhu; Li Zhang; Yan Huang

上一篇：SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer

下一篇：Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non–Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART)

互助时间线

2026-09-02 17:51:18 [完结求助]

楼主确认了论文小助手应助的文件是正确的, 求助状态变成 已完结

2026-09-02 17:49:26 [上传文件]

论文小助手上传了文件(pdf 599.61 KB), 求助状态变成 待确认

2026-09-02 17:38:58 [发起求助]

最新发布的求助

High prevalence of esophageal motility disorders in patients with rheumatologic diseases 44分钟前
Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer 52分钟前
Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non–Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART) 54分钟前
Izalontamab Brengitecan (Iza-Bren), a First-in-Class EGFR-HER3 Bispecific Antibody-Drug Conjugate in Extensive-Stage Small Cell Lung Cancer: Results From a Phase Ib Study 55分钟前
SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer 57分钟前
Impact of Genomic Subtype on Intracranial Outcomes in Treatment-naive EGFR mutant NSCLC with Osimertinib (IGnITE) 59分钟前
Disease Kinetics and Practice Patterns in ≥4-Year Long-Term Beneficiaries of Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer 1小时前
Comprehensive Patient Reported Outcomes (PROs) from NRG Oncology/Alliance LU005: A Randomized Trial Of Chemoradiation +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer 1小时前
Adverse Reactions to Bovine Collagen Implants 1小时前
Is There a Bilingual Advantage in Implicit and Explicit Phonetic Imitation? 1小时前
Phonetic imitation of coarticulatory vowel nasalization 1小时前
Phonetic imitation of coarticulatory vowel nasalization 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com